Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05008055
Title Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications

follicular lymphoma

mantle cell lymphoma

marginal zone B-cell lymphoma

Therapies

Capivasertib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN

Additional content available in CKB BOOST